Free Trial
→ Trump Orders 'National Digital Asset Stockpile' (From Crypto 101 Media) (Ad) Buy SXTP Stock  Free SXTP Stock Alerts

60 Degrees Pharmaceuticals (SXTP) SEC Filings & 10K Form

60 Degrees Pharmaceuticals logo
$3.16 -0.01 (-0.32%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$3.18 +0.01 (+0.47%)
As of 04/17/2025 06:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent 60 Degrees Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
04/09/2025
7:31 AM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2025
11:15 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form EFFECT
02/14/2025
4:21 PM		60 Degrees Pharmaceuticals (Subject)
60 DEGREES PHARMACEUTICALS, INC. (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
Form SCHEDULE 13G/A
02/11/2025
4:23 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form D
Notice of Exempt Offering of Securities 
02/11/2025
3:53 PM		60 Degrees Pharmaceuticals (Subject)
60 DEGREES PHARMACEUTICALS, INC. (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
Form SCHEDULE 13G
02/06/2025
9:04 AM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 424B5
02/03/2025
3:05 PM		60 Degrees Pharmaceuticals (Subject)
60 DEGREES PHARMACEUTICALS, INC. (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
Form SCHEDULE 13G
01/30/2025
4:30 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2025
7:28 AM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 424B5
01/24/2025
3:51 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
MILLER TYRONE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
3:52 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
DOW GEOFFREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
3:58 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
MILLER TYRONE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
4:00 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
DOW GEOFFREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:05 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
7:35 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
XU CHERYL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
4:07 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
DOW GEOFFREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
5:14 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
DOW GEOFFREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
12:44 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
3:01 PM		60 Degrees Pharmaceuticals (Subject)
60 DEGREES PHARMACEUTICALS, INC. (Subject)
Knight Therapeutics Inc (Filed by)
Form SC 13G/A
11/06/2024
4:26 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
2:46 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form DEF 14A
10/08/2024
7:17 AM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
9:56 AM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form PRE 14A
09/30/2024
11:15 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form EFFECT
09/19/2024
3:30 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/11/2024
3:46 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
XU CHERYL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2024
2:59 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
9:29 AM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
11:03 AM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
3:15 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
12:21 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 424B5
07/24/2024
4:05 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 424B5
07/22/2024
10:23 AM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 424B5
07/18/2024
11:15 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form EFFECT
07/16/2024
4:28 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
4:02 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/09/2024
2:37 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
4:06 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2024
4:26 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2024
1:15 PM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form DEF 14A
05/21/2024
7:22 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
MILLER TYRONE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s Top Secret $9 Trillion AI Superweapon (Ad)

Jeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that could benefit.

Nvidia’s early days made millionaires. This AI play might too.
05/21/2024
7:23 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
TOOVEY STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
7:23 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
XU CHERYL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
7:18 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
Allen Charles W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
7:19 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
DOW GEOFFREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
7:20 PM		60 Degrees Pharmaceuticals (Issuer)
60 DEGREES PHARMACEUTICALS, INC. (Issuer)
FIELD PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
10:56 AM		60 Degrees Pharmaceuticals (Filer)
60 DEGREES PHARMACEUTICALS, INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
6:19 PM		60 Degrees Pharmaceuticals (Subject)
60 DEGREES PHARMACEUTICALS, INC. (Subject)
KNIGHT THERAPEUTICS INTERNATIONAL SA (Filed by)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:SXTP) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners
Trump’s Top Secret $9 Trillion AI Superweapon
Jeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...
Brownstone Research | Sponsored
My prediction is coming true
We've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...
InvestorPlace | Sponsored
Musk’s AI Masterplan – Our #1 AI Stock to Buy Now
Did Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...
Behind the Markets | Sponsored
Why Elon put $51 million into this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
M.A.G.A. is Finished – This Could be even Better
You’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...
Paradigm Press | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
My friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...
Crypto Swap Profits | Sponsored
DOGE tax surprise
Elon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...
Altimetry | Sponsored